Matthew P. Lech

890 total citations · 1 hit paper
9 papers, 477 citations indexed

About

Matthew P. Lech is a scholar working on Biomedical Engineering, Molecular Biology and Epidemiology. According to data from OpenAlex, Matthew P. Lech has authored 9 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Biomedical Engineering, 3 papers in Molecular Biology and 3 papers in Epidemiology. Recurrent topics in Matthew P. Lech's work include 3D Printing in Biomedical Research (4 papers), Liver Disease Diagnosis and Treatment (2 papers) and Diet and metabolism studies (2 papers). Matthew P. Lech is often cited by papers focused on 3D Printing in Biomedical Research (4 papers), Liver Disease Diagnosis and Treatment (2 papers) and Diet and metabolism studies (2 papers). Matthew P. Lech collaborates with scholars based in United States, Switzerland and Denmark. Matthew P. Lech's co-authors include Alan Man, Jeffrey R. Morgan, Anthony P. Napolitano, Don Ho, Dylan M. Dean, Franklin Schlerman, Ken Dower, Shoh Asano, Neil C. Henderson and James B. McMahon and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Hepatology.

In The Last Decade

Matthew P. Lech

8 papers receiving 475 citations

Hit Papers

Identification of a broadly fibrogenic macrophage subset ... 2023 2026 2024 2025 2023 50 100 150

Peers

Matthew P. Lech
Choongseong Han South Korea
Jessica Llewellyn United States
Asako Tajima United States
Hai Jin China
Matthew P. Lech
Citations per year, relative to Matthew P. Lech Matthew P. Lech (= 1×) peers Wei‐Wen Liu

Countries citing papers authored by Matthew P. Lech

Since Specialization
Citations

This map shows the geographic impact of Matthew P. Lech's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew P. Lech with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew P. Lech more than expected).

Fields of papers citing papers by Matthew P. Lech

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew P. Lech. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew P. Lech. The network helps show where Matthew P. Lech may publish in the future.

Co-authorship network of co-authors of Matthew P. Lech

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew P. Lech. A scholar is included among the top collaborators of Matthew P. Lech based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew P. Lech. Matthew P. Lech is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Fabre, Thomas, Alex Barron, Stephen M. Christensen, et al.. (2023). Identification of a broadly fibrogenic macrophage subset induced by type 3 inflammation. Science Immunology. 8(82). eadd8945–eadd8945. 157 indexed citations breakdown →
2.
Luu, Rebeccah J., Ashley L. Gard, Miles Rogers, et al.. (2023). Fibroblast activation in response to TGFβ1 is modulated by co-culture with endothelial cells in a vascular organ-on-chip platform. Frontiers in Molecular Biosciences. 10. 1160851–1160851. 6 indexed citations
3.
Ju, Wang, Agustin Casimiro‐Garcia, Bryce G. Johnson, et al.. (2023). A protein kinase C α and β inhibitor blunts hyperphagia to halt renal function decline and reduces adiposity in a rat model of obesity-driven type 2 diabetes. Scientific Reports. 13(1). 16919–16919.
4.
Rogers, Miles, Ashley L. Gard, Thomas J. Mulhern, et al.. (2021). A high-throughput microfluidic bilayer co-culture platform to study endothelial-pericyte interactions. Scientific Reports. 11(1). 12225–12225. 33 indexed citations
5.
Ross, Trenton T., Collin Crowley, Kenneth L. Kelly, et al.. (2020). Acetyl-CoA Carboxylase Inhibition Improves Multiple Dimensions of NASH Pathogenesis in Model Systems. Cellular and Molecular Gastroenterology and Hepatology. 10(4). 829–851. 69 indexed citations
6.
Ross, Trenton T., Anthony Rinaldi, Matthew P. Lech, et al.. (2019). PS-132-The acetyl-CoA carboxylase inhibitor PF-05221304 exerts direct effects on hepatic inflammation and fibrosis independent of benefits on steatosis. Journal of Hepatology. 70(1). e86–e86. 1 indexed citations
7.
Sawant‐Basak, Aarti, A. David Rodrigues, Matthew P. Lech, et al.. (2018). Physiologically Relevant, Humanized Intestinal Systems to Study Metabolism and Transport of Small Molecule Therapeutics. Drug Metabolism and Disposition. 46(11). 1581–1587. 12 indexed citations
8.
Dower, Ken, Shanrong Zhao, Franklin Schlerman, et al.. (2017). High resolution molecular and histological analysis of renal disease progression in ZSF1 fa/faCP rats, a model of type 2 diabetic nephropathy. PLoS ONE. 12(7). e0181861–e0181861. 13 indexed citations
9.
Napolitano, Anthony P., Dylan M. Dean, Alan Man, et al.. (2007). Scaffold-Free Three-Dimensional Cell Culture Utilizing Micromolded Nonadhesive Hydrogels. BioTechniques. 43(4). 494–500. 186 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026